D.E. Shaw & Co’s Zura Bio ZURA Stock Holding History

D.E. Shaw & Co’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-106,597	Closed	-$1.09M	–	4928
2022 Q4	$1.09M	Hold	106,597	–	–	﹤0.01%	3381
2022 Q3	$1.07M	Hold	106,597	–	–	﹤0.01%	3545
2022 Q2	$1.06M	Hold	106,597	–	–	﹤0.01%	3593
2022 Q1	$1.06M	Buy	106,597 +18,000	+20%	+$177K	﹤0.01%	3874
2021 Q4	$874K	Buy	+88,597	New	+$874K	﹤0.01%	4037

Other funds holding ZURA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

D.E. Shaw & Co's ZURA Position: Q1 2023 in Review

D.E. Shaw & Co sold out of Zura Bio (ZURA) in Q1 2023, closing a stake of 106,597 shares — an estimated $1.09M sold.

D.E. Shaw & Co first reported a position in ZURA in Q4 2021 and held it in 5 quarters. The position peaked at $1.09M in Q4 2022. 3 funds tracked by Wall St. Rank hold ZURA as of Q1 2023.

D.E. Shaw & Co reported no remaining Zura Bio position as of Q1 2023 after selling out during the quarter.
D.E. Shaw & Co sold 106,597 Zura Bio shares in Q1 2023, an estimated $1.09M.
D.E. Shaw & Co first reported a position in Zura Bio in Q4 2021 and held it in 5 quarters.
D.E. Shaw & Co's Zura Bio position peaked at $1.09M in Q4 2022.
3 funds tracked by Wall St. Rank held Zura Bio as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.